Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular and Clinical Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9450 Online ISSN: 2049-9469
Journal Cover
October-2020 Volume 13 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2020 Volume 13 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Case Report Open Access

Proton beam therapy combined with retrograde intra‑arterial infusion chemotherapy for an extremely rapid growing recurrent ameloblastic carcinoma: A case report

  • Authors:
    • Kanako Takayama
    • Tatsuya Nakamura
    • Akinori Takada
    • Takahiro Kato
    • Hideo Sakuma
    • Kenji Mitsudo
    • Nobukazu Fuwa
    • Masao Murakami
  • View Affiliations / Copyright

    Affiliations: Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Koriyama, Fukushima 963‑8052, Japan, Department of Radiology, Mie University Hospital, Tsu, Mie 514‑8507, Japan, Department of Pathology, Southern Tohoku General Hospital, Koriyama, Fukushima 963‑8563, Japan, Department of Oral and Maxillofacial Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236‑0004, Japan, Department of Radiation Oncology, Ise Red Cross Hospital, Ise, Mie 516‑0008, Japan
    Copyright: © Takayama et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 34
    |
    Published online on: July 30, 2020
       https://doi.org/10.3892/mco.2020.2104
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Ameloblastic carcinoma (AC) is a very rare malignant odontogenic tumor. Although surgical resection is generally performed, treatment approaches have not been established for recurrent cases. Chemotherapy and radiotherapy are positioned as adjunctive therapies, and few studies investigated definitive non‑operative therapy. We present the case of a 71‑year‑old male with recurrent secondary‑type AC arising from the right maxilla, who was treated with proton beam therapy (PBT; 71.4 Gy relative biological effectiveness in 32 fractions) combined with continuous intra‑arterial infusion of cisplatin (40 mg/m2) and docetaxel (8 mg/m2). The patient experienced acute grade 3 mucositis, dermatitis and neutropenia, which were resolved within 3 months of treatment. Late adverse events were grade 1 skin atrophy, and grade 2 right optic nerve disorder and retinopathy. After ~8 years of treatment, the patient died from another cause but did not experience any relapse or metastasis during the follow‑up period of 94 months. To the best of our knowledge, this is the first report of recurrent AC treated with PBT and intra‑arterial infusion chemotherapy without any severe late adverse events. This combination therapy approach may be considered as an effective therapeutic option for inoperable AC.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Yoon HJ, Hong SP, Lee JI, Lee SS and Hong SD: Ameloblastic carcinoma: An analysis of 6 cases with review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 108:904–913. 2009.PubMed/NCBI View Article : Google Scholar

2 

Benlyazid A, Lacroix-Triki M, Aziza R, Gomez-Brouchet A, Guichard M and Sarini J: Ameloblastic carcinoma of the maxilla: Case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 104:e17–e24. 2007.PubMed/NCBI View Article : Google Scholar

3 

Kumaran PS, Anuradha V, Gokkulakrishnan S, Thambiah L, Jagadish AK and Satheesh G: Ameloblastic carcinoma: A case series. J Pharm Bioallied Sci. 6 (Suppl 1):S208–S211. 2014.PubMed/NCBI View Article : Google Scholar

4 

Fomete B, Adebayo ET, Ayuba GI and Okeke UA: Ameloblastic carcinoma of the maxilla: A report of two cases and a review of the literature. J Korean Assoc Oral Maxillofac Surg. 42:43–46. 2016.PubMed/NCBI View Article : Google Scholar

5 

Uzawa N, Suzuki M, Miura C, Tomomatsu N, Izumo T and Harada K: Primary ameloblastic carcinoma of the maxilla: A case report and literature review. Oncol Lett. 9:459–467. 2015.PubMed/NCBI View Article : Google Scholar

6 

Goldenberg D, Sciubba J, Koch W and Tufano RP: Malignant odontogenic tumors: A 22-year experience. Laryngoscope. 114:1770–1774. 2004.PubMed/NCBI View Article : Google Scholar

7 

Datta R, Winston JS, Diaz-Reyes G, Loree TR, Myers L, Kuriakose MA, Rigual NR and Hicks WL Jr: Ameloblastic carcinoma: Report of an aggressive case with multiple bony metastases. Am J Otolaryngol. 24:64–69. 2003.PubMed/NCBI View Article : Google Scholar

8 

Strojan P, Vermorken JB, Beitler JJ, Saba NF, Haigentz M Jr, Bossi P, Worden FP, Langendijk JA, Eisbruch A, Mendenhall WM, et al: Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review. Head Neck. 38:e2151–e2158. 2016.PubMed/NCBI View Article : Google Scholar

9 

Fuwa N, Ito Y, Matsumoto A, Kamata M, Kodaira T, Furutani K, Sasaoka M, Kimura Y and Morita K: A combination therapy of continuous superselective intraarterial carboplatin infusion and radiation therapy for locally advanced head and neck carcinoma. Phase I study. Cancer. 89:2099–2105. 2000.PubMed/NCBI

10 

Robbins KT, Storniolo AM, Kerber C, Vicario D, Seagren S, Shea M, Hanchett C, Los G and Howell SB: Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol. 12:2113–2120. 1994.PubMed/NCBI View Article : Google Scholar

11 

Mitsudo K, Koizumi T, Iida M, Iwai T, Nakashima H, Oguri S, Kioi M, Hirota M, Koike I, Hata M and Tohnai I: Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: Analysis of therapeutic results in 112 cases. Radiother Oncol. 111:306–310. 2014.PubMed/NCBI View Article : Google Scholar

12 

Perera E, Lindquist C, Hughes C and Thomas S: The use of Gamma Knife stereotactic radiosurgery in the treatment of ameloblastic carcinoma. Int J Oral Maxillofac Surg. 42:934–938. 2013.PubMed/NCBI View Article : Google Scholar

13 

Koca T, Başaran H, Arslan D, Sezen D, Cerkeşli ZA, Kılınç O, Karaca S, Başsorgun CI, Okay HO and Demirci M: Prominent response with helical tomotherapy in recurrent ameloblastic carcinoma of maxillary sinus: A case report. Radiat Oncol. 9(157)2014.PubMed/NCBI View Article : Google Scholar

14 

Aoki T, Akiba T, Kondo Y, Sasaki M, Kajiwara H and Ota Y: The use of radiation therapy in the definitive management of ameloblastic carcinoma: A case report. Oral Surg Oral Med Oral Pathol Oral Radiol. 127:e56–e60. 2019.PubMed/NCBI View Article : Google Scholar

15 

Jensen AD, Ecker S, Ellerbrock M, Nikoghosyan A, Debus J and Münter MW: Carbon ion therapy for ameloblastic carcinoma. Radiat Oncol. 6(13)2011.PubMed/NCBI View Article : Google Scholar

16 

Yamagata K, Ishikawa H, Saito T and Bukawa H: Proton beam therapy for ameloblastic carcinoma of the maxilla: Report of a rare case. J Oral Maxillofac Surg. 77:227.e1–227.e5. 2019.PubMed/NCBI View Article : Google Scholar

17 

Fokas E, Kraft G, An H and Engenhart-Cabillic R: Ion beam radiobiology and cancer: Time to update ourselves. Biochim Biophys Acta. 1796:216–229. 2009.PubMed/NCBI View Article : Google Scholar

18 

Urie MM, Sisterson JM, Koehler AM, Goitein M and Zoesman J: Proton beam penumbra: Effects of separation between patient and beam modifying devices. Med Phys. 13:734–741. 1986.PubMed/NCBI View Article : Google Scholar

19 

Patel SH, Wang Z, Wong WW, Murad MH, Buckey CR, Mohammed K, Alahdab F, Altayar O, Nabhan M, Schild SE and Foote RL: Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: A systematic review and meta-analysis. Lancet Oncol. 15:1027–1038. 2014.PubMed/NCBI View Article : Google Scholar

20 

Fuwa N, Kodaira T, Furutani K, Tachibana H and Nakamuta T: A new method of selective intra-arterial infusion therapy via the superficial temporal artery for head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 105:78378–78379. 2008.PubMed/NCBI View Article : Google Scholar

21 

Nakamura T, Fuwa N, Takayama K, Inokuchi H, Tomoda T, Takada A, Makita C, Shiomi M, Yokouchi J and Watanabe K: Phase I study of weekly docetaxel and cisplatin arterial infusion for recurrent head and neck cancer. Head Neck. 34:1634–1639. 2012.PubMed/NCBI View Article : Google Scholar

22 

Yabuuchi H, Kuroiwa T, Tajima T, Tomita K, Ochiai N and Kawamoto K: Efficacy of intra-arterial infusion therapy using a combination of cisplatin and docetaxel for recurrent head and neck cancers compared with cisplatin alone. Clin Oncol (R Coll Radiol). 15:467–472. 2003.PubMed/NCBI View Article : Google Scholar

23 

Torres MA, Chang EL, Mahajan A, Lege DG, Riley BA, Zhang X, Lii M, Kornguth DG, Pelloski CE and Woo SY: Optimal treatment planning for skull base chordoma: Photons, protons, or a combination of both? Int J Radiat Oncol Biol Phys. 74:1033–1039. 2009.PubMed/NCBI View Article : Google Scholar

24 

Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. Published May 28, 2009; Revised version 4.03 June 14, 2010. https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf. Accessed July 12, 2019.

25 

Saluja TS and Hosalkar R: Reconnoitre ameloblastic carcinoma: A prognostic update. Oral Oncol. 77:118–124. 2018.PubMed/NCBI View Article : Google Scholar

26 

Simko EJ, Brannon RB and Eibling DE: Ameloblastic carcinoma of the mandible. Head Neck. 20:654–659. 1998.PubMed/NCBI View Article : Google Scholar

27 

Infante-Cossio P, Hernandez-Guisado JM, Fernandez-Machin P, Garcia-Perla A, Rollon-Mayordomo A and Gutierrez-Perez JL: Ameloblastic carcinoma of the maxilla: A report of 3 cases. J Craniomaxillofac Surg. 26:159–162. 1998.PubMed/NCBI View Article : Google Scholar

28 

Philip M, Morris CG, Werning JW and Mendenhall WM: Radiotherapy in the treatment of ameloblastoma and ameloblastic carcinoma. J HK Coll Radiol. 8:157–161. 2005.

29 

Atkinson CH, Harwood AR and Cummings BJ: Ameloblastoma of the jaw: A reappraisal of the role of megavoltage irradiation. Cancer. 53:869–873. 1984.PubMed/NCBI View Article : Google Scholar

30 

Demizu Y, Fujii O, Terashima K, Mima M, Hashimoto N, Niwa Y, Akagi T, Daimon T, Murakami M and Fuwa N: Particle therapy for mucosal melanoma of the head and neck. A single-institution retrospective comparison of proton and carbon ion therapy. Strahlenther Onkol. 190:186–191. 2014.PubMed/NCBI View Article : Google Scholar

31 

Endo H, Takayama K, Mitsudo K, Nakamura T, Seto I, Yamaguchi H, Ono T, Suzuki M, Azami Y, Wada H, et al: Proton beam therapy in combination with intra-arterial infusion chemotherapy for T4 squamous cell carcinoma of the maxillary gingiva. Cancers (Basel). 10(333)2018.PubMed/NCBI View Article : Google Scholar

32 

Tang Y, Luo D, Peng W, Huang F and Peng Y: Ocular ischemic syndrome secondary to carotid artery occlusion as a late complication of radiotherapy of nasopharyngeal carcinoma. J Neuroophthalmol. 30:315–320. 2010.PubMed/NCBI View Article : Google Scholar

33 

Gupta A, Dhawahir-Scala F, Smith A, Young L and Charles S: Radiation retinopathy: Case report and review. BMC Ophthalmol. 7(6)2007.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Takayama K, Nakamura T, Takada A, Kato T, Sakuma H, Mitsudo K, Fuwa N and Murakami M: Proton beam therapy combined with retrograde intra‑arterial infusion chemotherapy for an extremely rapid growing recurrent ameloblastic carcinoma: A case report. Mol Clin Oncol 13: 34, 2020.
APA
Takayama, K., Nakamura, T., Takada, A., Kato, T., Sakuma, H., Mitsudo, K. ... Murakami, M. (2020). Proton beam therapy combined with retrograde intra‑arterial infusion chemotherapy for an extremely rapid growing recurrent ameloblastic carcinoma: A case report. Molecular and Clinical Oncology, 13, 34. https://doi.org/10.3892/mco.2020.2104
MLA
Takayama, K., Nakamura, T., Takada, A., Kato, T., Sakuma, H., Mitsudo, K., Fuwa, N., Murakami, M."Proton beam therapy combined with retrograde intra‑arterial infusion chemotherapy for an extremely rapid growing recurrent ameloblastic carcinoma: A case report". Molecular and Clinical Oncology 13.4 (2020): 34.
Chicago
Takayama, K., Nakamura, T., Takada, A., Kato, T., Sakuma, H., Mitsudo, K., Fuwa, N., Murakami, M."Proton beam therapy combined with retrograde intra‑arterial infusion chemotherapy for an extremely rapid growing recurrent ameloblastic carcinoma: A case report". Molecular and Clinical Oncology 13, no. 4 (2020): 34. https://doi.org/10.3892/mco.2020.2104
Copy and paste a formatted citation
x
Spandidos Publications style
Takayama K, Nakamura T, Takada A, Kato T, Sakuma H, Mitsudo K, Fuwa N and Murakami M: Proton beam therapy combined with retrograde intra‑arterial infusion chemotherapy for an extremely rapid growing recurrent ameloblastic carcinoma: A case report. Mol Clin Oncol 13: 34, 2020.
APA
Takayama, K., Nakamura, T., Takada, A., Kato, T., Sakuma, H., Mitsudo, K. ... Murakami, M. (2020). Proton beam therapy combined with retrograde intra‑arterial infusion chemotherapy for an extremely rapid growing recurrent ameloblastic carcinoma: A case report. Molecular and Clinical Oncology, 13, 34. https://doi.org/10.3892/mco.2020.2104
MLA
Takayama, K., Nakamura, T., Takada, A., Kato, T., Sakuma, H., Mitsudo, K., Fuwa, N., Murakami, M."Proton beam therapy combined with retrograde intra‑arterial infusion chemotherapy for an extremely rapid growing recurrent ameloblastic carcinoma: A case report". Molecular and Clinical Oncology 13.4 (2020): 34.
Chicago
Takayama, K., Nakamura, T., Takada, A., Kato, T., Sakuma, H., Mitsudo, K., Fuwa, N., Murakami, M."Proton beam therapy combined with retrograde intra‑arterial infusion chemotherapy for an extremely rapid growing recurrent ameloblastic carcinoma: A case report". Molecular and Clinical Oncology 13, no. 4 (2020): 34. https://doi.org/10.3892/mco.2020.2104
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team